Unmodified carbonyl compounds are converted in an enantioselective aldol-Tishchenko reaction directly into the chiral adduct by using catalytic amounts of a chiral base prepared in situ [Eq. (1)]. The catalyst was developed through the combination of arrayed catalyst evaluation and informed ligand design. Ad=adamantyl.
No takes yet. Share an insight, caveat, or question.
Mascarenhas et al. (2001) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: